Lack of association between ABCB1 gene polymorphisms and pharmacoresistant epilepsy: An analysis in a western Chinese pediatric population

Dong Lin(Ministry of Education of the People's Republic of China), Dan Yu(The Affiliated Yongchuan Hospital of Chongqing Medical University), Rong Luo(Boston Children's Hospital), Xiaotang Cai(Sichuan University), Tong Yu(Shenyang Pharmaceutical University), Meng Mao(Guiyang Medical University)
Brain Research
April 19, 2011
10.1016/j.brainres.2011.03.028
Cited by 38

Related Papers

A Lancet Commission on 70 years of women's reproductive, maternal, newborn, child, and adolescent health in China
|The Lancet|2021|579
Burosumab Therapy in Children with X-Linked Hypophosphatemia
|New England Journal of Medicine|2018|479
Prevalence of Autism Spectrum Disorder in China: A Nationwide Multi-center Population-based Study Among Children Aged 6 to 12 Years
|Neuroscience Bulletin|2020|468
Olig2 Targets Chromatin Remodelers to Enhancers to Initiate Oligodendrocyte Differentiation
|Cell|2013|384
Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial
|The Lancet|2019|375